Marcella Wyatt

University of Bristol

Papers

1

Total Citations

73

H-Index

1

About

Marcella Wyatt is a leading translational neuroscientist whose work focuses on overcoming the blood-brain barrier (BBB) to improve treatment outcomes for patients with glioblastoma. Her most impactful contribution is the development of a novel implantable catheter system with a transcutaneous port for intermittent convection-enhanced delivery (CED) of carboplatin, a chemotherapeutic agent that otherwise fails to penetrate the BBB effectively. This landmark study, which has garnered 73 citations, demonstrated a viable strategy to bypass the BBB and deliver high concentrations of carboplatin directly to recurrent glioblastoma tumors, addressing a critical failure point in systemic chemotherapy. Wyatt’s research bridges the gap between preclinical innovation and clinical application, offering a tangible solution to improve drug delivery in one of the most aggressive brain cancers. Her work has been instrumental in advancing CED as a therapeutic platform, and her catheter system represents a significant step toward more effective, localized treatment for patients with limited options.

Research Focus

Key Achievements

1
H-Index
1
Papers
73
Total Citations
73
Avg Citations/Paper
🏆 Most Cited Paper
A novel implantable catheter system with transcutaneous port for intermittent convection-enhanced delivery of carboplatin for recurrent glioblastoma
73 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: University of Bristol

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago